Hypoglycemia in the neonate: current controversies

Area of Science:

• Neonatal Medicine
• Endocrinology
• Pediatric Neurology

Background:

• Current debates surround neonatal hypoglycemia's definition, bedside monitoring accuracy, and its neurological effects.
• Historical data influencing current understanding of neonatal blood glucose levels are limited by outdated methodologies and lack of consideration for medical and nutritional management.
• The perception of increased brain tolerance to low glucose in preterm infants is not supported by evidence.

Purpose of the Study:

• To review controversies in neonatal hypoglycemia, including definition, monitoring, and neurological outcomes.
• To propose a functional definition of hypoglycemia based on maintaining normal brain function.
• To suggest a pragmatic approach to monitoring and treating at-risk neonates.

Main Methods:

• Review of historical and current literature on neonatal hypoglycemia.
• Analysis of existing controversies regarding biochemical definitions and bedside glucose monitoring.
• Discussion of the relationship between neonatal symptoms, metabolic status, treatment, and neurological outcomes.

Main Results:

• No evidence supports differential brain glucose tolerance between preterm and term infants.
• A proposed definition for hypoglycemia is the lowest glucose concentration supporting normal brain function.
• Current bedside monitoring methods are inadequate for accurate neonatal glucose assessment.

Conclusions:

• Neonatal hypoglycemia is a continuum, not a single threshold.
• A pragmatic approach involves monitoring infants at risk (glucose < 2.6 mmol/L) especially around feedings.
• Future research should integrate fuel concentrations, neurophysiology, and intervention trials with long-term follow-up.